Shenyang Xingqi Pharmaceutical Co.,Ltd
300573.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.7B
Close$
Share Statistics
| Market cap | $12.70 Billion |
|---|---|
| Enterprise Value | $12.31 Billion |
| Dividend Yield | $1.48 (3.66%) |
| Earnings per Share | $2.83 |
| Beta | 0.24 |
| Outstanding Shares | 357,322,814 |
Return
| Return on Equity | 36.59% |
|---|---|
| Return on Assets | 28.83% |
| Return on Invested Capital | 40.37% |
Valuation & Multiples
| P/E Ratio | 12.09 |
|---|---|
| PEG | 65.16 |
| Price to Sales | 4.87 |
| Price to Book Ratio | 5.69 |
| Enterprise Value to Revenue | 4.54 |
| Enterprise Value to EBIT | 13.7 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shenyang Xingqi Pharmaceutical Co.,Ltd
2,396 employees
CEO: E. Gao Shenyang Xingqi Pharmaceutical Co., Ltd, based in Shenyang, China, specializes in the comprehensive process of creating, producing, and distributing ophthalmological products throughout the Chinese market. The company offers a diverse po...